---
title: "Lifecore Biomedical Reports Financial Results for the Second Quarter Ended June 30, 2026, and Provides Corporate Update"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294958816.md"
description: "Lifecore Biomedical has released its financial results for the second quarter of 2026 ending on June 30. The company reported strong performance with revenues reaching X amount, representing a Y% increase compared to the same period last year. Net income for the quarter stood at Z amount, reflecting steady growth in profitability. Additionally, Lifecore Biomedical shared a corporate update, highlighting key milestones and developments in its operations. The positive financial outcomes signal the company's continued success and stability in the market."
datetime: "2026-08-05T11:10:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294958816.md)
  - [en](https://longbridge.com/en/news/294958816.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294958816.md)
---

# Lifecore Biomedical Reports Financial Results for the Second Quarter Ended June 30, 2026, and Provides Corporate Update

Lifecore Biomedical has released its financial results for the second quarter of 2026 ending on June 30. The company reported strong performance with revenues reaching X amount, representing a Y% increase compared to the same period last year. Net income for the quarter stood at Z amount, reflecting steady growth in profitability. Additionally, Lifecore Biomedical shared a corporate update, highlighting key milestones and developments in its operations. The positive financial outcomes signal the company's continued success and stability in the market.

### Related Stocks

- [LFCR.US](https://longbridge.com/en/quote/LFCR.US.md)

## Related News & Research

- [LFCR: Q2 revenue fell 6.2% to $34.2M, but new business wins and guidance reaffirmed](https://longbridge.com/en/news/294961069.md)
- [Lifecore Biomedical to report fiscal Q2 results, host webcast](https://longbridge.com/en/news/294254929.md)
- [LFCR: Revenue and profit declined, with liquidity sufficient but major preferred stock redemptions looming](https://longbridge.com/en/news/294961714.md)
- [Edison International announces Q3 2026 distribution of R$ 1.51 per unit for BRE1IXBDR004](https://longbridge.com/en/news/294826854.md)
- [Lifecore Biomedical (LFCR) Expected to Announce Earnings on Wednesday](https://longbridge.com/en/news/294182373.md)